• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项双中心研究:超声放射组学能否区分 CA125 水平正常的Ⅰ型和Ⅱ型上皮性卵巢癌患者?

A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?

机构信息

The Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Department of Ultrasound, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.

出版信息

Br J Radiol. 2024 Oct 1;97(1162):1706-1712. doi: 10.1093/bjr/tqae144.

DOI:10.1093/bjr/tqae144
PMID:39177575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11417353/
Abstract

OBJECTIVE

CA125 is recommended by many countries as the primary screening test for ovarian cancer. But there are patients with ovarian cancer having normal CA125. We hope to identify the types of EOC with normal CA125 levels better by building a refined model based on the ultrasound radiomics, thus providing precise medical treatment for patients.

METHODS

We included 58 patients with EOC with normal CA125 from 2 centres, who were confirmed by preoperative ultrasound and pathology. We extracted 1130 radiomics features based on the tumour's region of interest from the most typical ultrasound image of each patient. We selected radiomics and clinical features by LASSO and logistic regression to construct Rad-score and clinical models, respectively. Receiver operating characteristic curves judged their test efficacy. On the basis of the combined model, we developed a nomogram.

RESULTS

Area under the curves (AUCs) of 0.93 and 0.83 were achieved in both the training and test groups for the combined model. There were similar AUCs between the Rad-score and clinical models of 0.82 and 0.80, respectively. By analysing the calibration curves, it was determined that the nomogram matched actual observations in the training cohort.

CONCLUSION

Ultrasound radiomics can differentiate type I and type II EOC with normal CA125 levels.

ADVANCES IN KNOWLEDGE

This study is the first to focus on EOC cases with normal level of CA125. The subset of patients constituting 20% of the disease population may require more refined radiomics models.

摘要

目的

许多国家推荐 CA125 作为卵巢癌的主要筛查试验。但有些卵巢癌患者的 CA125 正常。我们希望通过构建基于超声放射组学的精细模型,更好地识别 CA125 水平正常的卵巢上皮癌(EOC)类型,从而为患者提供精准的医疗服务。

方法

我们纳入了来自 2 个中心的 58 例 CA125 正常的 EOC 患者,这些患者通过术前超声和病理得到证实。我们从每位患者最典型的超声图像中提取了 1130 个基于肿瘤感兴趣区的放射组学特征。我们通过 LASSO 和逻辑回归选择放射组学和临床特征,分别构建 Rad-score 和临床模型。受试者工作特征曲线判断它们的测试效果。在此基础上,我们开发了一个列线图。

结果

训练组和测试组的联合模型的曲线下面积(AUC)分别为 0.93 和 0.83。Rad-score 模型和临床模型的 AUC 分别为 0.82 和 0.80,两者相似。通过分析校准曲线,发现列线图在训练队列中与实际观察结果相符。

结论

超声放射组学可区分 CA125 水平正常的 I 型和 II 型 EOC。

知识进展

本研究首次聚焦于 CA125 水平正常的 EOC 病例。占疾病人群 20%的这部分患者可能需要更精细的放射组学模型。

相似文献

1
A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?一项双中心研究:超声放射组学能否区分 CA125 水平正常的Ⅰ型和Ⅱ型上皮性卵巢癌患者?
Br J Radiol. 2024 Oct 1;97(1162):1706-1712. doi: 10.1093/bjr/tqae144.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125.在化疗期间及随访过程中,通过血清肿瘤标志物CA125对卵巢癌患者进行监测。
Dan Med J. 2018 Apr;65(4).
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Radiomics Nomogram Based on Optimal Volume of Interest Derived from High-Resolution CT for Preoperative Prediction of IASLC Grading in Clinical IA Lung Adenocarcinomas: A Multi-Center, Large-Population Study.基于高分辨率 CT 最优感兴趣区体积的放射组学列线图预测临床 IA 期肺腺癌 IASLC 分级:多中心大样本研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241300734. doi: 10.1177/15330338241300734.
7
Building radiomics models based on ACR TI-RADS combining clinical features for discriminating benign and malignant thyroid nodules.基于美国放射学会甲状腺影像报告和数据系统(ACR TI-RADS)构建联合临床特征的影像组学模型以鉴别甲状腺良恶性结节。
Front Endocrinol (Lausanne). 2025 Jul 21;16:1486920. doi: 10.3389/fendo.2025.1486920. eCollection 2025.
8
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
9
Deep Learning Radiomics Nomogram Based on MRI for Differentiating between Borderline Ovarian Tumors and Stage I Ovarian Cancer: A Multicenter Study.基于MRI的深度学习影像组学列线图用于鉴别卵巢交界性肿瘤和Ⅰ期卵巢癌:一项多中心研究
Acad Radiol. 2025 Jun;32(6):3485-3497. doi: 10.1016/j.acra.2024.12.067. Epub 2025 Jan 14.
10
CT-based radiomics model for noninvasive prediction of progression-free survival in high-grade serous ovarian carcinoma: a multicenter study incorporating preoperative and postoperative clinical factors.基于CT的影像组学模型用于高级别浆液性卵巢癌无进展生存期的无创预测:一项纳入术前和术后临床因素的多中心研究
BMC Med Imaging. 2025 Aug 8;25(1):320. doi: 10.1186/s12880-025-01865-0.

本文引用的文献

1
Nomogram based on ultrasound radiomics score and clinical variables for predicting histologic subtypes of epithelial ovarian cancer.基于超声放射组学评分和临床变量的列线图预测上皮性卵巢癌的组织学亚型。
Br J Radiol. 2022 Aug 1;95(1136):20211332. doi: 10.1259/bjr.20211332. Epub 2022 Jun 9.
2
Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer.基于超声的放射组学评分:一种预测卵巢上皮癌无进展生存期的潜在生物标志物。
Abdom Radiol (NY). 2021 Oct;46(10):4936-4945. doi: 10.1007/s00261-021-03163-z. Epub 2021 Jun 13.
3
Predicting intraventricular hemorrhage growth with a machine learning-based, radiomics-clinical model.基于机器学习的放射组学-临床模型预测脑室内出血的增长。
Aging (Albany NY). 2021 May 4;13(9):12833-12848. doi: 10.18632/aging.202954.
4
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records.CA125检测结果、检测至诊断间隔时间与卵巢癌诊断时的分期:一项使用电子健康记录的回顾性队列研究
Br J Gen Pract. 2021 May 27;71(707):e465-e472. doi: 10.3399/BJGP.2020.0859. Print 2021 Jun.
5
CA125 and Ovarian Cancer: A Comprehensive Review.CA125与卵巢癌:一篇综述
Cancers (Basel). 2020 Dec 11;12(12):3730. doi: 10.3390/cancers12123730.
6
Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer.CA125、HE4、DDI和FDP在II型上皮性卵巢癌中的相关性分析及临床意义
Medicine (Baltimore). 2020 Dec 4;99(49):e23329. doi: 10.1097/MD.0000000000023329.
7
MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers.基于磁共振成像的放射组学区分Ⅰ型和Ⅱ型上皮性卵巢癌。
Eur Radiol. 2021 Jan;31(1):403-410. doi: 10.1007/s00330-020-07091-2. Epub 2020 Aug 2.
8
The Adoption of Radiomics and machine learning improves the diagnostic processes of women with Ovarian MAsses (the AROMA pilot study).基于影像组学和机器学习的诊断方法改善了卵巢肿块患者的诊断过程(AROMA 初步研究)。
J Ultrasound. 2021 Dec;24(4):429-437. doi: 10.1007/s40477-020-00503-5. Epub 2020 Jul 21.
9
Radiomics Based on Thyroid Ultrasound Can Predict Distant Metastasis of Follicular Thyroid Carcinoma.基于甲状腺超声的影像组学可预测滤泡状甲状腺癌的远处转移。
J Clin Med. 2020 Jul 8;9(7):2156. doi: 10.3390/jcm9072156.
10
MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes.磁共振成像在卵巢上皮性癌中的应用:一种预测组织学亚型的联合模型。
Eur Radiol. 2020 Nov;30(11):5815-5825. doi: 10.1007/s00330-020-06993-5. Epub 2020 Jun 13.